Archive · 20 Aug 2026
Nanded University Secures Indian Patent for Tuberculosis Nano-Drug Delivery
A university in Nanded, Maharashtra, has received an Indian patent for a new medicine-delivery technology.
The technology uses extremely tiny structures called nanostructures.
It is meant for tuberculosis medicines that do not dissolve well in water.
Medicines that dissolve poorly can be harder for the body to use effectively.
The new system may help deliver these drugs better inside the body.
The university said this could improve their therapeutic effectiveness.
The patent is called “Nanostructured Delivery Device for Poorly Water-Soluble Anti-Tubercular Drugs and Method Thereof.”
It will remain valid for 20 years.
Swami Ramanand Teerth Marathwada University in Nanded has secured an Indian patent.
The patent covers a nanostructured delivery device for poorly water-soluble anti-tubercular drugs.
The technology is designed to improve how these medicines are delivered in the body.
The university said improved delivery could enhance the drugs’ therapeutic effectiveness.
The patent has been granted for 20 years.
- Who
- Swami Ramanand Teerth Marathwada University in Nanded.
- What
- It secured an Indian patent for a nanostructured delivery system for poorly water-soluble anti-tubercular drugs.
- When
- The university announced the patent on Wednesday; it has been granted for 20 years.
- Where
- Nanded, Maharashtra, India.
- Why
- To improve the delivery and potential therapeutic effectiveness of poorly water-soluble tuberculosis medicines.
- Institution
- Swami Ramanand Teerth Marathwada University
- Location
- Nanded, Maharashtra
- Patent title
- Nanostructured Delivery Device for Poorly Water-Soluble Anti-Tubercular Drugs and Method Thereof
- Patent jurisdiction
- India
- Patent term
- 20 years
- Technology
- Nanostructured delivery system for poorly water-soluble anti-tubercular drugs